review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Guochao Shi | |
Chunrong Huang | |||
P2860 | cites work | Analysis of the lung microbiome in the "healthy" smoker and in COPD | Q21091065 |
Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans | Q21133618 | ||
Disordered microbial communities in asthmatic airways | Q21562589 | ||
New Insights into Inflammatory Bowel Disease Pathophysiology: Paving the Way for Novel Therapeutic Targets | Q22241332 | ||
Innate Immunity in Crohnʼs Disease | Q22242728 | ||
Recent Insights Into the Genetics of Inflammatory Bowel Disease | Q22250935 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors | Q22252931 | ||
Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins | Q24621817 | ||
Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis | Q24669753 | ||
Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients | Q24814235 | ||
Acute exacerbation of COPD | Q26749302 | ||
COPD and the microbiome | Q26768514 | ||
Inflammatory bowel disease as a model for translating the microbiome | Q26853123 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Cystic fibrosis | Q28250200 | ||
Crohn's disease | Q28273481 | ||
Cigarette smoking and infection | Q28292345 | ||
The effects of airway microbiome on corticosteroid responsiveness in asthma | Q28392911 | ||
Pathogens and host immunity in the ancient human oral cavity | Q28660564 | ||
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | Q28710518 | ||
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease | Q28727685 | ||
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
Tobacco smoke and involuntary smoking | Q29619429 | ||
Lung infections associated with cystic fibrosis | Q30080000 | ||
Bacterial species diversity in cigarettes linked to an investigation of severe pneumonitis in U.S. Military personnel deployed in operation iraqi freedom | Q30991677 | ||
Subacute Bacterial Endocarditis with Leptotrichia goodfellowii in a Patient with a Valvular Allograft: A Case Report and Review of the Literature. | Q31145208 | ||
Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals | Q33509530 | ||
Human pathogens abundant in the bacterial metagenome of cigarettes | Q33523227 | ||
Invasion strategies of the oral pathogen porphyromonas gingivalis: implications for cardiovascular disease | Q33655174 | ||
Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota | Q33779241 | ||
Disordered microbial communities in the upper respiratory tract of cigarette smokers | Q33781228 | ||
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma | Q33782854 | ||
Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma | Q33793577 | ||
Smoking, use of moist snuff and risk of celiac disease: a prospective study | Q33864904 | ||
Smoking and increased Alzheimer's disease risk: a review of potential mechanisms | Q33902721 | ||
Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. | Q33907451 | ||
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. | Q33995488 | ||
The Human Microbiome Project in 2011 and beyond | Q34054038 | ||
The ecology of genetically diverse infections | Q34250505 | ||
Composition of tobaccos from countries with high and low incidences of lung cancer. I. Selenium, polonium-210, Alternaria, tar, and nicotine. | Q34273537 | ||
Higher rates of Clostridium difficile infection among smokers | Q34359509 | ||
Inflammatory bowel disease and tobacco smoke--a case-control study | Q34393276 | ||
Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect | Q34410437 | ||
Periodontal microbial ecology | Q34413957 | ||
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations | Q34437958 | ||
The lung microbiome in moderate and severe chronic obstructive pulmonary disease | Q34448176 | ||
Bicuspid aortic valve endocarditis caused by Gemella sanguinis: Case report and literature review | Q91166867 | ||
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential | Q91975122 | ||
Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells | Q93070834 | ||
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer | Q93347337 | ||
Environmental risk factors for inflammatory bowel disease | Q93587626 | ||
Chemokine and cytokine levels in inflammatory bowel disease patients | Q36338594 | ||
Functional Metagenomics of the Bronchial Microbiome in COPD. | Q36345407 | ||
A tale of two risks: smoking, diabetes and the subgingival microbiome. | Q36378549 | ||
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. | Q36431204 | ||
Recovery of Mycobacterium avium from cigarettes | Q36525509 | ||
Smoking rates and the state of smoking interventions for children and adolescents with chronic illness | Q36554209 | ||
The cystic fibrosis airway microbiome | Q36629083 | ||
Smoking as a trigger for inflammatory rheumatic diseases | Q36672505 | ||
Multicenter case-control study of the risk factors for ulcerative colitis in China | Q36715099 | ||
Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. | Q36850868 | ||
Microbiology of odontogenic bacteremia: beyond endocarditis | Q37050956 | ||
Comparison of the respiratory microbiome in healthy nonsmokers and smokers | Q37073006 | ||
Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease | Q37189929 | ||
The long-term stability of the human gut microbiota | Q37217949 | ||
Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. | Q37317826 | ||
Cigarette smoking and innate immunity | Q37358532 | ||
Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus | Q37487983 | ||
The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. | Q37501328 | ||
Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis | Q37502050 | ||
Oral microbiome and history of smoking and colorectal cancer | Q37590332 | ||
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients | Q37594836 | ||
Effects of tobacco smoke on immunity, inflammation and autoimmunity | Q37665006 | ||
The intestinal microbiota in inflammatory bowel diseases: time to connect with the host | Q37743105 | ||
Diabetes mellitus and periodontitis: a tale of two common interrelated diseases | Q37895120 | ||
Impact of cigarette smoke exposure on host-bacterial pathogen interactions. | Q37898894 | ||
The oral microbiome in health and disease | Q38064217 | ||
Chronic ulcerative colitis and colorectal cancer | Q38128638 | ||
Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). | Q38214520 | ||
Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. | Q38263963 | ||
Current perspective of the impact of smoking on the progression and treatment of periodontitis | Q38286146 | ||
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. | Q38657093 | ||
Effects of smoking on oral ecology. A review of the literature | Q38738959 | ||
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease | Q39227281 | ||
Biofilms and host response - helpful or harmful | Q39240791 | ||
Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. | Q39297856 | ||
Serial pH changes in the duodenal bulb during smoking | Q39310469 | ||
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers | Q39413531 | ||
Cigarette smoking and the oral microbiome in a large study of American adults | Q39889154 | ||
Opportunistic Infection: A Review | Q40013750 | ||
Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. | Q40231814 | ||
Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator | Q40349670 | ||
Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study | Q40501515 | ||
Bacterial infection as a cause of cancer | Q41064472 | ||
Studies on the erythropoietic effect of plasma from anemic toads both with and without testis | Q41733373 | ||
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice | Q42263596 | ||
Identification of bacterial and fungal components in tobacco and tobacco smoke | Q43008480 | ||
Allergenic fungi and actinomycetes in smoking materials and their health implications | Q43021037 | ||
NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. | Q43118703 | ||
Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction | Q43504466 | ||
Neutrophil superoxide production in the presence of cigarette smoke extract, nicotine and cotinine | Q43516494 | ||
Mucosal flora in Crohn's disease and ulcerative colitis - an overview. | Q43784311 | ||
Case report: severe acute Parkinsonism associated with streptococcal infection and antibasal ganglia antibodies | Q43941017 | ||
Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis | Q44216697 | ||
Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status | Q44264832 | ||
The differential effect of cigarette smoke on the growth of bacteria found in humans | Q44277886 | ||
Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis | Q34536205 | ||
Frequent detection of Streptococcus tigurinus in the human oral microbial flora by a specific 16S rRNA gene real-time TaqMan PCR. | Q34537955 | ||
Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. | Q34577688 | ||
Intestinal microbiota in inflammatory bowel disease: friend of foe? | Q34579729 | ||
The subgingival microbiome of clinically healthy current and never smokers. | Q34760422 | ||
Microbiota disbiosis is associated with colorectal cancer | Q35037563 | ||
Bacterial infections as a cause of cancer | Q35096949 | ||
Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease | Q35114878 | ||
Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi | Q35120262 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
Subgingival microbiota in health compared to periodontitis and the influence of smoking | Q35169436 | ||
Emerging cystic fibrosis pathogens and the microbiome | Q35169553 | ||
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. | Q35250967 | ||
Subgingival microbiome in smokers and non-smokers in Korean chronic periodontitis patients | Q35302484 | ||
Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies | Q35328218 | ||
Advancing respiratory research | Q35410986 | ||
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
Gut microbiome development along the colorectal adenoma-carcinoma sequence | Q35574864 | ||
Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa. | Q35646925 | ||
Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites | Q35671726 | ||
The Influence of Smoking on the Peri-Implant Microbiome | Q35678207 | ||
Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements | Q35681203 | ||
The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment | Q35716503 | ||
The airway microbiome in patients with severe asthma: Associations with disease features and severity. | Q35721479 | ||
Cigarette smoking and the periodontal patient | Q35739602 | ||
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters | Q35773313 | ||
Immunopathogenesis of IBD: current state of the art. | Q35857951 | ||
Subgingival Microbial Profiles of Smokers with Periodontitis | Q35866602 | ||
Asthma and cigarette smoking. | Q35933941 | ||
The lung microbiome and exacerbations of COPD. | Q35952878 | ||
XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented? | Q35956144 | ||
Genotoxicity of tobacco smoke and tobacco smoke condensate: a review | Q35968076 | ||
Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes | Q35989768 | ||
Emerging pathogenic links between microbiota and the gut-lung axis. | Q36150861 | ||
Cigarette smoking and the microbial flora of the mouth | Q44889612 | ||
Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers | Q46249728 | ||
Airway microbiota across age and disease spectrum in cystic fibrosis | Q46259966 | ||
Smoking May Lead to Marginal Bone Loss Around Non-Submerged Implants During Bone Healing by Altering Salivary Microbiome: A Prospective Study. | Q46315884 | ||
Cigarette smoke effects on innate immune mechanisms in the nasal mucosa. Potential effects on the microbiome | Q46584455 | ||
Cigarette smoking inhibits acid-stimulated duodenal mucosal bicarbonate secretion | Q46602834 | ||
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer | Q46663786 | ||
Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. | Q46720733 | ||
The gut microbiome in health and disease | Q46913518 | ||
Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer | Q47657457 | ||
Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis | Q47750206 | ||
Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers | Q47782465 | ||
Maturation of the gut microbiome and risk of asthma in childhood | Q48267558 | ||
Current smoking improves ulcerative colitis patients' disease behaviour in the northwest of China | Q49372195 | ||
Mutagenicity of pyrolysates of salt-tolerant bacteria from food and cigarettes | Q50211789 | ||
Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study. | Q50928110 | ||
Subgingival microbiome in smokers and non-smokers in periodontitis: an exploratory study using traditional targeted techniques and a next-generation sequencing. | Q51535370 | ||
Alterations in Enteric Virome Associate With Colorectal Cancer and Survival Outcomes. | Q54229182 | ||
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. | Q54348400 | ||
Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis. | Q54380862 | ||
Rheumatoid arthritis: Prevotella copri associated with new-onset untreated RA. | Q54536068 | ||
Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome | Q57022552 | ||
Types of tobacco consumption and the oral microbiome in the United Arab Emirates Healthy Future (UAEHFS) Pilot Study | Q57174461 | ||
Association between Cigarette Smoking Status and Composition of Gut Microbiota: Population-Based Cross-Sectional Study | Q58198306 | ||
Influence of cigarette smoking on the human duodenal mucosa-associated microbiota | Q58694782 | ||
A metagenomic study of the gut microbiome in Behcet's disease | Q58800559 | ||
Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention | Q59411245 | ||
Effects of smoking on the lower respiratory tract microbiome in mice | Q60044802 | ||
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
subspecies engineered to produce mycosporin-like amino acids in colorectal cancer prevention | Q61812084 | ||
Streptococcus sanguinis biofilm formation & interaction with oral pathogens. | Q64973509 | ||
Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion | Q67744478 | ||
Two cases of "heavy chain disease" | Q71059205 | ||
Gastric cancer | Q73738910 | ||
The prevalence of pathogenic periodontal microflora in healthy young adult smokers | Q73781214 | ||
Bacterial endotoxin is an active component of cigarette smoke | Q74619159 | ||
Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis | Q76390548 | ||
Subgingival plaque microbiota in HIV positive patients | Q79797755 | ||
Recovery of potential pathogens in the nasopharynx of healthy and otitis media-prone children and their smoking and nonsmoking parents | Q79820554 | ||
Fecal microbiota in early rheumatoid arthritis | Q81403677 | ||
Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease | Q81458923 | ||
Tobacco flakes on cigarette filters grow bacteria: a potential health risk to the smoker? | Q81924438 | ||
The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases | Q84002918 | ||
Cigarette smoke decreases organic acids levels and population of bifidobacterium in the caecum of rats | Q84236971 | ||
Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin | Q84488767 | ||
Periodontal disease in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003) | Q84564250 | ||
Effects of cigarette smoke condensate on the production and characterization of exopolysaccharides by Bifidobacterium | Q85349548 | ||
Insights into the human oral microbiome | Q88153217 | ||
Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection | Q89567847 | ||
P433 | issue | 1 | |
P304 | page(s) | 225 | |
P577 | publication date | 2019-07-15 | |
P1433 | published in | Journal of Translational Medicine | Q15716664 |
P1476 | title | Smoking and microbiome in oral, airway, gut and some systemic diseases | |
P478 | volume | 17 |
Q91720343 | Looking Higher: Is It Prime Time for the Oral-Lung Axis in HIV-related Lung Disease? |
Q99582945 | Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms |
Q129711783 | Pipe smoking and oral health in males from The Netherlands during the 18th–19th century |